The challenge to develop breakthrough medicines for the treatment of dementia and other neurodegenerative diseases is vast and requires a collective effort.
At Eisai we actively pursue partnerships with academic institutions, non-profit organisations or other companies, to find new therapeutic approaches that will ultimately meet the needs of patients and their carers.
The External Innovation team is central to establishing neurology-based partnerships; with the overall aim of sharing knowledge, resources and expertise to achieve mutually beneficial outcomes.
While we remain open-minded in our approach, we are particularly interested in new targets, enabling technologies and concepts that are built on robust human disease-based evidence (pathological and / or genetic) with strong translational potential.
If you would like to discuss how you can join us in our mission to develop the next generation of neurodegeneration therapies, please connect with us.